Overview of Radiosensitivity of Human Tumor Cells to Low-Dose-Rate Irradiation

International Journal of Radiation Oncology Biology Physics

Volumn 72, Issue 3, 2008, Pages 909-917

  Williams, Jerry R ^a,b   Zhang, Yonggang ^b   Zhou, Haoming ^b   Gridley, Daila S ^a   Koch, Cameron J ^c   Slater, James M ^a   Little, John B ^d  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cell cycle; Clonogenic survival; Human tumor cells; Ionizing radiation; Low dose rate

Indexed keywords

CELL CULTURE; CELLS; FLOW CYTOMETRY; IMAGING TECHNIQUES; IRRADIATION; MICROSCOPIC EXAMINATION; RADIATION; TUMORS;

CELL CYCLE; CELL CYCLING; CELL LINES; CELLULAR RADIOSENSITIVITY; CLINICAL APPLICATIONS; CLONOGENIC SURVIVAL; DOSE-RATE EFFECTS; FUNCTION OF TIME; GLIOMA CELLS; HIGH-DOSE; HUMAN TUMOR CELLS; INDUCED LOSSES; IONIZING RADIATION; LOW DOSE RATES; LOW-DOSE-RATE; TIME-DEPENDENT; TIME-DEPENDENT MODELS; TUMOR CELL LINES; WILD-TYPE;

CYTOLOGY;

ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; FLOW CYTOMETRY; GENOTYPE; GLIOMA CELL; HUMAN; HUMAN CELL; IRRADIATION; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY; TUMOR CELL;

CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MUTATION; NEOPLASMS; RADIATION TOLERANCE;

EID: 52949089683     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.06.1928     Document Type: Article

References (33)

1. Williams J.R., Zhang Y., Russell J., et al. Human tumor cells segregate into radiosensitivity groups that associate with ATM and TP53 status. Acta Oncol 46 (2007) 628-638
2. Williams J., Zhang Y., Russell J., et al. Quantitative overview of human tumor radiosensitivity across histological type and TP53 status. Int J Radiat Biol 84 (2008) 253-264
3. Gridley D.S., Williams J.R., and Slater J.M. Low-dose/low-dose-rate radiation: A feasible strategy to improve cancer radiotherapy?. Cancer Ther 3 (2005) 105-130
4. Elkind M.M., and Sutton H. X-Ray damage and recovery in mammalian cells in culture. Nature 184 (1959) 1293-1295
5. Terasima T., and Tolmach L.J. Changes in x-ray sensitivity of HeLa cells during the division cycle. Nature 190 (1961) 1210-1211
6. Lajtha L.G., and Oliver R. Cell population kinetics following different regimes of irradiation. Br J Radiol 35 (1962) 131-140
7. Bedford J.S., and Hall E.J. Survival of HeLa cells cultured in vitro and exposed to protracted gamma-irradiation. Int J Radiat Biol Relat Studies Phys Chem Med 45 (1963) 377-383
8. Hall E.J., and Bedford J.S. Dose rate: Its effect on the survival of HeLa cells irradiated with gamma rays. Radiat Res 22 (1964) 305-315
9. Bedford J.S., and Mitchell J.B. Dose-rate effects in synchronous mammalian cells in culture. Radiat Res 54 (1973) 316-327
10. Hall E.J., and Brenner D.J. The dose-rate effect revisited: Radiobiological considerations of importance in radiotherapy. Int J Radiat Oncol Biol Phys 21 (1991) 1403-1414
11. Mitchell J.B., and Bedford J.S. Dose-rate effects in synchronous mammalian cells in culture. II. A comparison of the life cycle of HeLa cells during continuous irradiation or multiple-dose fractionation. Radiat Res 71 (1977) 547-560
12. Mitchell J.B., Bedford J.S., and Bailey S.M. Dose-rate effects on the cell cycle and survival of S3 HeLa and V79 cells. Radiat Res 79 (1979) 520-536
13. Mitchell J.B., Bedford J.S., and Bailey S.M. Dose-rate effects in plateau-phase cultures of S3 HeLa and V79 cells. Radiat Res 79 (1979) 552-567
14. van Oostrum I.E.A., Erkens-Schulze S., Petterson M., et al. The relationship between radiosensitivity and cell kinetic effects after low- and high-dose-rate irradiation in five human tumors in nude mice. Radiat Res 122 (1990) 252-261
15. 2/M-phase block and other radiobiological parameters. Radiat Res 135 (1993) 24-31
16. Bristow R.G., Benchimol S., and Hill R.P. The p53 gene as a modifier of intrinsic radiosensitivity: Implications for radiotherapy. Radiother Oncol 40 (1996) 197-223
17. Dahm-Daphi J. p53: Biology and role for cellular radiosensitivity. Strahlenther Onkol 76 (2003) 278-285
18. Matsui Y., Tscuchida Y., and Keng P.C. Effects of p53 mutations on cellular sensitivity to ionizing radiation. Am J Clin Oncol 24 (2001) 486-490
19. Weber K.J., and Wenz F. p53; Apoptosis and radiosensitivity-Experimental and clinical data. Onkologie 25 (2003) 136-141
20. Hartwell L.H., and Wiener T.A. Checkpoints: Controls that ensure the order of cell cycle events. Science 246 (1989) 629-634
21. Bernhard E.J., Maity A., Muschel R.J., et al. Effects of ionizing radiation on cell cycle progression. A review. Radiat Environ Biophys 34 (1995) 79-83
22. McIlwrath A.J., Vasey P.A., Ross G.M., and Brown R. Cell cycle arrests and radiosensitivity of human tumor cell lines: Dependence on wild-type p53 for radiosensitivity. Cancer Res 54 (1994) 3718-3722
23. Pellegata N.S., Antoniono R.J., Redpath J.L., et al. DNA damage and p53-mediated cell cycle arrest: A reevaluation. Proc Natl Acad Sci U S A 93 (1996) 15209-15214
24. Williams J.R., Zhang Y., Zhou H., et al. Genotype-dependent radiosensitivity: Clonogenic survival, apoptosis and redistribution in the cell cycle. Int J Radiat Biol 84 (2008) 151-164
25. Fertil B., and Malaise E.P. Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: Analysis of 101 published survival curves. Int J Radiat Oncol Biol Phys 11 (1985) 1699-1707
26. Malaise E.P., Fertil B., Chavaudra N., et al. Distribution of radiation sensitivities for human tumor cells of specific histological types: Comparison of in vitro to in vivo data. Int J Radiat Oncol Biol Phys 12 (1986) 617-624
27. West C.M., Davidson S.E., Roberts S.A., et al. The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix. Br J Cancer 76 (1997) 1184-1190
28. Jones B., Dale R.G., Deehan C., et al. The role of biologically effective dose (BED) in clinical oncology. Clin Oncol (R Coll Radiol) 13 (2001) 71-81
29. Fowler J.F. The radiobiology of prostate cancer including new aspects of fractionated radiotherapy. Acta Oncol 44 (2005) 265-276
30. Haustermans K., and Withers H.R. The biological basis of fractionation. Rays 29 (2004) 231-236
31. Williams J.R., Zhang Y., and Dillehay L.E. Sensitization processes in human tumor cells during protracted irradiation: Possible exploitation in the clinic. Int J Radiat Oncol Biol Phys 24 (1992) 699-704
32. Williams J.A., Williams J.R., Xuan Y., et al. Protracted exposure radiosensitization of experimental human malignant glioma. Radiat Oncol Invest 6 (1998) 255-263
33. Yuan X., Dillehay L.E., Williams J.R., et al. IUdR polymers for combined continuous low-dose rate sensitization of experimental malignant gliomas. Int J Cancer 96 (2001) 118-125